ライフサイエンスコーパス: tumor immunology

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 cant clinical implications to both viral and tumor immunology.

2 d the potentially important role of CD200 in tumor immunology.

3 in the fields of infection, vaccination, and tumor immunology.

4 ng evidence supporting a role for B cells in tumor immunology.

5 dysfunction remains an unresolved problem of tumor immunology.

6 ys a central role in infectious diseases and tumor immunology.

7 priming of antitumor CTL is well accepted in tumor immunology.

8 ranslated may have important implications in tumor immunology.

9 dels has lagged behind developments in human tumor immunology.

10 ideal combination cancer therapies based on tumor immunology.

11 ith the potential for both basic research in tumor immunology and clinical stratification of patients

12 This fusion of tumor immunology and genetics is leading to new ways to

13 considers insights into basic neurobiology, tumor immunology, and autoimmune neuronal degeneration o

14 ces in our understanding of basic aspects of tumor immunology, and suggest how these insights can lea

15 d in a series of AACR conferences, entitled "Tumor Immunology: Basic and Clinical Advances," was held

16 These antigens are of particular interest in tumor immunology, because their expression, with excepti

17 The eight articles in this Review series on tumor immunology discuss the mechanisms underlying immun

18 rscore the importance of understanding basic tumor immunology for successful clinical translation in

19 ials and some recent advances in fundamental tumor immunology give hope for improvement in future the

20 role of T cells and natural killer cells in tumor immunology has been established, less is known abo

21 e much of the focus on T cell dysfunction in tumor immunology has been, and appropriately so, on brea

22 mor cells and specimens, its precise role in tumor immunology has not been defined.

23 In addition, recent advances in tumor immunology have broadened our understanding of the

24 Concurrently, advances in tumor immunology have led to the development of immunomo

25 However, several recent key advances in tumor immunology have now turned the tide in favor of im

26 Studies in tumor immunology have relied upon the classic paradigm o

27 umor cells and a heightened understanding of tumor immunology have resulted in efforts to activate ho

28 Great progress has been made in the field of tumor immunology in the past decade, but optimism about

29 Recent studies in tumor immunology indicate that malignant cells frequentl

30 o underpin numerous aspects of inflammation, tumor immunology, infectious disease, and autoimmunity,

31 A major challenge in tumor immunology is how best to activate the relatively

32 A major agenda for tumor immunology is the generation of specific immune re

33 One enigma in tumor immunology is why animals bearing malignant grafts

34 In tumor immunology, it has always been postulated that tum

35 This paradox in tumor immunology led us to address two questions: (a) Do

36 evaluating immunotherapies and for defining tumor immunology paradigms.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。